FDA Investigator Jose A Cruz
Jose A Cruz has inspections in 8 countries as of 03 Nov 2023. Jose A Cruz has collaborated with a combined 2685 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
32
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Switzerland,
United States of America,
Spain,
Canada,
France,
Germany,
Puerto Rico,
Japan
Co-Investigator(s):
Adalberto Cajigas,
Adaliz Santaliz Cruz,
Agnes M Santori,
Alan A Rivera,
Anastasia G Lolas,
Angelica M Hernandez,
Ann L Demarco,
Ann Marie Montemurro,
Annette Melendez,
Ariel Cruz Figueroa,
Arlene M Badillo,
Arsen Karapetyan,
Barbara M Frazier,
Brandon C Heitmeier,
Brenda Rivera,
Carl A Anderson,
Carlos A Medina,
Cassandra L Abellard,
CDR Ileana Barreto Pettit,
Charles I Ann,
Charles M Edwards,
Cheryl A Clausen,
Constance Y Fears,
Dayna I Martinez,
Doan T Nguyen, PharmD,
Don H Bark, PhD,
Douglas C Kovacs,
Edwin Martinez,
Eliezar Ramos,
German Rivera,
Gloria E Parra,
Gwyn G Dickinson,
Helen B Ricalde,
Iraida Ortiz,
Ivis L Negron,
Ivis Lnegron Torres,
James L Dunnie, Jr,
James P Mcevoy,
Jason K Morgan,
Javier O Vega,
Jeffrey A Sommers,
Jeffrey B Medwid, PhD,
Joey V Quitania,
John P Mistler,
Jorge E Martinez,
Jorge L Guadalupe,
Jorge L Lajara,
Jose A Lopez,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
José E Meléndez,
Jose E Melendez, DDC,
Jose F Pedro,
Jose Fpedrode Jesus,
Jose R Lopez,
Jose Rflores Veguilla,
Jose Rflores Vequilla,
Jose Velez,
Julie D Bringger,
Karl D Hezel,
Katherine E Jacobitz,
Kathleen D Culver,
Kenneth H Williams,
Kent C Faul,
Kevin A Gonzalez,
Kevin D Kallander,
Kim Lthomas Cruse,
Kip J Hanks,
Kristina L Conroy,
Laiza V Garcia,
Laura E Garcia,
Laurimer Kuilan Torres,
Libia M Lugo,
Lisa M Bellows,
Lourdes Andujar,
Luella J Rossi,
Luis Soto Lopez,
Maria A Ruttell,
Marian E Ramirez,
Marie A Fadden,
Marie F Morin,
Marilyn Santiago,
Matthew B Casale,
Maxwell Van Tassell, PhD,
Michael E Maselli,
Michael Levy,
Michael R Goga,
Michele L Obert,
Michelle Y Clark Stuart,
Miguel A Martinez,
Milva E Melendez,
Min Tang,
Minh D Phan,
Mra Mcculloughj,
Muralidhara B Gavini, PhD,
Myriam M Sosa,
Nadeem I Chaudhry,
Nancy G Schmidt,
Nancy N Bellamy,
Noreen Muniz,
Omotunde O Osunsanmi,
Pablo Feliciano,
Paraluman S Leonin,
Parul M Patel,
Patricia Fhughes Troost,
Patrick C Klotzbuecher,
Patsy J Domingo,
Paul A Bonneau,
Paul L Bellamy,
Peter R Lenahan,
Prabhu P Raju,
Rafael Nevarez Nieves,
Ralph H Vocque,
Ramesh Potla, PhD,
Ramon A Hernandez,
Raquel Gonzalez Rivera,
Raymond T Oji,
Rebeca M Melendez,
Rebecca Parrilla,
Rebecca Rodriguez,
Regina T Brown,
Robert C Coleman,
Robert C Steyert,
Robert J Martin,
Robert Q Jennings,
Robert W Jennings,
Russell J Glapion,
Sangeeta M Khurana, PhD,
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Sixto M Mercado,
Sixto M Mercado Rios,
Sonia M Monges,
Stephanie D Crockett,
Stephen D Brown,
Steven B Barber,
Susan O Oladeji,
Thomas E Friel,
Thomas J Arista,
Thomas W Nojek,
Uttaniti Limchumroon (Tom),
Victor J Gangi,
Vilmary Negron Rodriguez,
Wanda J Torres,
Yanming An, PhD,
Yasamin Ameri,
Yumi J Hiramine,
Zhong Li, PhD
Jose A Cruz's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more